{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T08:40:14Z","timestamp":1783068014662,"version":"3.54.6"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2005,6,3]],"date-time":"2005-06-03T00:00:00Z","timestamp":1117756800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1038\/sj.eye.6701932","type":"journal-article","created":{"date-parts":[[2005,6,3]],"date-time":"2005-06-03T09:42:45Z","timestamp":1117791765000},"page":"583-590","source":"Crossref","is-referenced-by-count":39,"title":["The clinical validity of the treatment satisfaction survey for intraocular pressure in ocular hypertensive and glaucoma patients"],"prefix":"10.1038","volume":"20","author":[{"given":"D G","family":"Day","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E D","family":"Sharpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M J","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J A","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W C","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,6,3]]},"reference":[{"key":"BF6701932_CR1","doi-asserted-by":"publisher","first-page":"622","DOI":"10.7326\/0003-4819-118-8-199304150-00009","volume":"118","author":"GH Guyatt","year":"1993","unstructured":"Guyatt GH, Feeny DH, Patrick DL . Measuring health-related quality of life. Ann Intenr Med 1993; 118: 622\u2013629.","journal-title":"Ann Intenr Med"},{"key":"BF6701932_CR2","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/BF00422218","volume":"2","author":"RD Hays","year":"1993","unstructured":"Hays RD, Anderson R, Revicki D . Psychometric considerations in evaluating health-related quality of life measures. Qual Life Res 1993; 2: 441\u2013449.","journal-title":"Qual Life Res"},{"key":"BF6701932_CR3","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/00005650-198804000-00008","volume":"26","author":"J Ware","year":"1988","unstructured":"Ware J, Hays RD . Methods for measuring patient satisfaction with specific medical encounters. Med Care 1988; 26: 393\u2013402.","journal-title":"Med Care"},{"key":"BF6701932_CR4","first-page":"1059","volume":"43","author":"HD Jampel","year":"2002","unstructured":"Jampel HD, Friedman DS, Quigley H, Miller R . Correlation of the binocular visual field with patient assessment of vision. Invest Ophthalmol Vis Sci 2002; 43: 1059\u20131067.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BF6701932_CR5","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0008-4182(01)80082-X","volume":"36","author":"F Montemayer","year":"2001","unstructured":"Montemayer F, Sibley LM, Courtright P, Mikelberg FS . Contribution of multiple glaucoma medications to visual function and quality of life in patients with glaucoma. Can J Ophthalmol 2001; 36: 385\u2013390.","journal-title":"Can J Ophthalmol"},{"key":"BF6701932_CR6","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1001\/archopht.119.7.1050","volume":"119","author":"CM Mangione","year":"2001","unstructured":"Mangione CM, Lee PP, Gutierrez P, Spitzer K, Berry S, Hays RD . NEI-VFQ field test investigators. Development of the 25-item Nation eye institute visual functional questionnaire. Arch Ophthalmol 2001; 119: 1050\u20131058.","journal-title":"Arch Ophthalmol"},{"key":"BF6701932_CR7","first-page":"1057","volume":"23","author":"C Baudouin","year":"2000","unstructured":"Baudouin C, Bechetoille A, Bron A, Denis P, Nordmann JP, Renard JP et al. Relevance of quality of life and treatment compliance measurement in patients with chronic open-angle glaucoma. J Fr Ophthalmol 2000; 23: 1057\u20131064.","journal-title":"J Fr Ophthalmol"},{"key":"BF6701932_CR8","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1001\/archopht.116.7.861","volume":"116","author":"BL Lee","year":"1998","unstructured":"Lee BL, Gutierrez P, Gordon M, Wilson MR, Cioffi GA, Ritch R et al. The glaucoma symptom scale. A brief index of glaucoma-specific symptoms. Arch Ophthalmol 1998; 116: 861\u2013866.","journal-title":"Arch Ophthalmol"},{"key":"BF6701932_CR9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/00061198-200304000-00009","volume":"12","author":"P Nelson","year":"2003","unstructured":"Nelson P, Aspinall P, Papasouliotis O, Worton B, O'Brien C . Quality of life in glaucoma and its relationship with visual function. J Glaucoma 2003; 12: 139\u2013150.","journal-title":"J Glaucoma"},{"key":"BF6701932_CR10","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S0149-2918(96)80042-7","volume":"18","author":"R Laibovitz","year":"1996","unstructured":"Laibovitz R, Boyle J, Snyder E, Strohmaier K, Adamsons I . Dorzolamide vs pilocarpine as adjunctive therapies to timolol: a comparison of patient preference and impact on daily life. Clin Ther 1996; 18: 821\u2013832.","journal-title":"Clin Ther"},{"key":"BF6701932_CR11","unstructured":"Juniper EF . Interpreting of quality of life data. Qual Life Newslett 1999; 3."},{"key":"BF6701932_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1477-7525-1-67","volume":"1","author":"MJ Atkinson","year":"2003","unstructured":"Atkinson MJ, Stewart WC, Fain JM, Stewart JA, Dhawan R, Mozaffari E et al. A new measure of patient satisfaction with ocular hypotensive medications: The Treatment Satisfaction Survey\u2014Intraocular Pressure (TSS-IOP). Health Qual Life Outcomes 2003; 1: 67.","journal-title":"Health Qual Life Outcomes"},{"key":"BF6701932_CR13","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/S0002-9394(14)74225-4","volume":"103","author":"MA Kass","year":"1997","unstructured":"Kass MA, Gordon M, Morley Jr RE, Meltzer DW, Goldberg JJ . Compliance with topical timolol treatment. Am J Ophthalmol 1997; 103: 188\u2013193.","journal-title":"Am J Ophthalmol"},{"key":"BF6701932_CR14","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/0002-9394(86)90939-6","volume":"101","author":"MA Kass","year":"1986","unstructured":"Kass MA, Meltzer DW, Gordon M, Cooper D, Goldberg JJ . Compliance with topical pilocarpine treatment. Am J Ophthalmol 1986; 101: 515\u2013523.","journal-title":"Am J Ophthalmol"},{"key":"BF6701932_CR15","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1136\/bjo.66.7.464","volume":"66","author":"PA Granstr\u00f6m","year":"1982","unstructured":"Granstr\u00f6m PA . Glaucoma patients not compliant with their drug therapy: clinical and behavioral aspects. Br J Ophthalmol 1982; 66: 464\u2013470.","journal-title":"Br J Ophthalmol"},{"key":"BF6701932_CR16","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1089\/jop.2004.20.461","volume":"20","author":"WC Stewart","year":"2004","unstructured":"Stewart WC, Konstas AGP, Pfeiffer N . Patient and ophthalmologist attitudes concerning compliance and dosing in glaucoma treatment. J Ocular Pharmacol Ther 2004; 20: 461\u2013469.","journal-title":"J Ocular Pharmacol Ther"},{"key":"BF6701932_CR17","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/0002-9394(86)90940-2","volume":"101","author":"MA Kass","year":"1986","unstructured":"Kass MA, Gordon M, Meltzer DW . Can ophthalmologists correctly identify patients defaulting from pilocarpine treatment? Am J Ophthalmol 1986; 101: 524\u2013530.","journal-title":"Am J Ophthalmol"},{"key":"BF6701932_CR18","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1016\/S0161-6420(95)30798-1","volume":"102","author":"A Alm","year":"1995","unstructured":"Alm A, Stjernschantz J, the Scandinavian Latanoprost Study Group. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning: a comparison with timolol. Ophthalmology 1995; 102: 1743\u20131752.","journal-title":"Ophthalmology"},{"key":"BF6701932_CR19","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S0161-6420(96)30749-5","volume":"103","author":"CB Camras","year":"1996","unstructured":"Camras CB, the United States Latanoprost Study Group. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month, masked, multicenter trial in the United States. Ophthalmology 1996; 103: 138\u2013147.","journal-title":"Ophthalmology"},{"key":"BF6701932_CR20","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/S0161-6420(96)30750-1","volume":"103","author":"P Watson","year":"1996","unstructured":"Watson P, Stjernschantz J, the Latanoprost Study Group. A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. Ophthalmology 1996; 103: 126\u2013137.","journal-title":"Ophthalmology"},{"key":"BF6701932_CR21","doi-asserted-by":"publisher","first-page":"S361","DOI":"10.1016\/S0039-6257(01)00219-3","volume":"45","author":"M Sherwood","year":"2001","unstructured":"Sherwood M, Brandt J, Bimatoprost Study Groups 1 and 2. Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure. Surv Ophthalmol 2001; 45: S361\u2013S368.","journal-title":"Surv Ophthalmol"},{"key":"BF6701932_CR22","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/S0002-9394(02)01980-3","volume":"135","author":"WC Stewart","year":"2003","unstructured":"Stewart WC, Kolker AE, Stewart JA, Leech JN, Jackson AL . Conjunctival hyperemia in healthy subjects after short-term dosing with latanoprost, bimatoprost, and travoprost. Am J Ophthalmol 2003; 135: 314\u2013320.","journal-title":"Am J Ophthalmol"},{"key":"BF6701932_CR23","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/S0002-9394(03)00098-9","volume":"135","author":"RK Parrish","year":"2003","unstructured":"Parrish RK, Palmberg P, Sheu WP, XLT Study Group. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. Am J Ophthalmol 2003; 135: 688\u2013703.","journal-title":"Am J Ophthalmol"},{"key":"BF6701932_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0002-9394(02)01827-5","volume":"135","author":"RS Noecker","year":"2003","unstructured":"Noecker RS, Dirks MS, Choplin NT, Bernstein P, Batoosingh AL, Whitcup SM, Bimatoprost\/Latanoprost Study Group. A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma. Am J Ophthalmol 2003; 135: 55\u201363.","journal-title":"Am J Ophthalmol"},{"key":"BF6701932_CR25","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S0002-9394(01)01177-1","volume":"132","author":"PA Netland","year":"2001","unstructured":"Netland PA, Landry T, Sullivan EK, Andrew R, Silver L, Weiner A et al. Travoprost Study Group. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. Am J Ophthalmol 2001; 132: 472\u2013484.","journal-title":"Am J Ophthalmol"},{"key":"BF6701932_CR26","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/00061198-200312000-00006","volume":"12","author":"WC Stewart","year":"2003","unstructured":"Stewart WC, Stewart JA, Jenkins JN, Jackson AL . Corneal punctate staining with latanoprost, bimatoprost, and travoprost in healthy subjects. J Glaucoma 2003; 12: 475\u2013479.","journal-title":"J Glaucoma"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6701932.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6701932","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6701932.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:21:31Z","timestamp":1684412491000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6701932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6,3]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["BF6701932"],"URL":"https:\/\/doi.org\/10.1038\/sj.eye.6701932","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6,3]]}}}